Fresenius Medical Care AG/ DE0005785802 /
09/01/2025 16:29:36 | Chg. +0.09 | Volume | Bid09/01/2025 | Ask09/01/2025 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
43.55EUR | +0.21% | 78,304 Turnover: 1.69 mill. |
43.54Bid Size: 53 | 43.55Ask Size: 64 | 12.81 bill.EUR | 2.73% | 25.68 |
GlobeNewswire
10/06/2024
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
GlobeNewswire
07/05/2024
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
GlobeNewswire
24/04/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/02/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/02/2024
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velp...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire
24/08/2023
CIO Leadership: The Steps Needed to Build a High-Performance Culture Will Power the Discussion at th...
GlobeNewswire
29/03/2022
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
GlobeNewswire
14/03/2022
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire
01/03/2022
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results